• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《老年心脏病学杂志（英文版）》 >No association between low-dose reserpine use and depression in older hypertensive patient: result of a multicenter, cross-sectional study

No association between low-dose reserpine use and depression in older hypertensive patient: result of a multicenter, cross-sectional study

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background Reserpine is currently used by millions of Chinese hypertensive patients, in spite of the continued concern of its depressogenic effect, even when used in low dose. This study aimed to investigate the association between low-dose reserpine use and depression in older Chinese hypertensive patient. Methods In this cross-sectional, case-control study, we recruited patient aged 60 years or over who had regularly taken one or two tables of "compound reserpine and triamterene tablets（CRTTs）" for more than one year（reserpine user） from 26 community health centers located in 10 provinces in China. For each patient who took CRTTs, we selected an age（within five years） and sex matched hypertensive patient who had never taken any drugs containing reserpine（non-reserpine user） as control. Depressive symptoms were evaluated using a Chinese depression scale adapted from the Zung Self-Rating Depression Scale. Demographic, clinical data and laboratory examination results within six months were collected. Results From August 2018 to December 2018, 787 reserpine user and 787 non-reserpine user were recruited. The mean age of all study subjects was 70.3 years, with about equal numbers of males and females. The mean depression score was 40.4 in reserpine users and 40.6 in non-reserpine users（P = 0.7）. The majority of study subject had a depression score ＜ 53（87.6% in reserpine users and 88.2% in non-reserpine users, respectively）. There were no significant differences in the prevalence of mild, moderate or severe depression in reserpine users and non-reserpine users. Conclusions There is no association between low-dose reserpine use and depression in older hypertensive patient. The role of reserpine in the treatment and control of hypertension should be reconsidered; and further studies, especially randomized, controlled clinical trials to compare efficacy and safety of reserpine and other widely recommended anti-hypertensive agents are needed.

著录项

相似文献

  • 中文文献
  • 外文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号